Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors

NCT04258462 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Benign Kidney Neoplasm
Kidney Neoplasm
Renal Cell Cancer

Interventions

DRUG: Hyperpolarized Carbon C 13 Pyruvate
PROCEDURE: Magnetic Resonance Imaging
DRUG: Hyperpolarized 13C,15N2-urea

Sponsor

Zhen Wang, MD

Collaborators

[object Object]
[object Object]